You are here

  • Home
  • Archive
  • Volume 92, Issue 2
  • Intravenous thrombolysis for acute ischaemic stroke during COVID‐19 pandemic in Wuhan, China: a multicentre, retrospective cohort study

Article Text

Article menu
Download PDFPDF
PostScript
PostScript
Intravenous thrombolysis for acute ischaemic stroke during COVID‐19 pandemic in Wuhan, China: a multicentre, retrospective cohort study

https://doi.org/10.1136/jnnp-2020-324014

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • YZ, CH and JC contributed equally.

    • Contributors BH was responsible for the concept and design of the study. YZ did the literature search. YZ, SC and CH acquired and interpreted data. JC analyzed the data. YZ, CH and SC wrote the manuscript. DW revised the the manuscript. HJ, YL, YX, LM, YW and LZ did the administrative, technical, or material support. CP, JH and MH did the material support.

    • Funding This work was supported by the National Key Research and Development Program of China (No. 2018YFC1312200 to BH), the National Natural Science Foundation of China (No. 81820108010 to BH, NO. 81901212 to YFZ, NO. 81801172 to SCC), the Natural Science Foundation of Hubei Health Committee of China (No. WJ2019Q017 to MH).

    • Competing interests None declared.

    • Patient consent for publication Not required.

    • Ethics approval The study was performed in accordance to the principles of the Declaration of Helsinki and was approved by the Research Ethics Committee of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Number/ID：(2020)(0068).

    • Provenance and peer review Not commissioned; externally peer reviewed.